Rare diseases
Investigational molecules
Locations
Back to Italy920 clinical trials in Treviso, Italy across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)Study on BP1.7881 for Adults with Eosinophilic Esophagitis
ItalyStudy of Entrectinib for Patients with Advanced or Metastatic Solid Tumors with Specific Gene Changes
ItalyStudy on the Effectiveness of Decitabine and Tetrahydrouridine in Patients with Sickle Cell Disease Not Eligible for Hydroxyurea Treatment
ItalyStudy Comparing Daratumumab with Drug Combination for Young Patients with Newly Diagnosed Multiple Myeloma Eligible for Stem Cell Transplantation
ItalyStudy Comparing Talquetamab, Daratumumab, and Pomalidomide with Drug Combination for Patients with Relapsed or Refractory Multiple Myeloma
ItalyStudy on Vimseltinib for Patients with Tenosynovial Giant Cell Tumor
ItalyStudy of Pembrolizumab for Patients with Early Stage Non-Small Cell Lung Cancer After Surgery and Standard Therapy
ItalyStudy of Teclistamab and Lenalidomide as Maintenance Treatment for Newly Diagnosed Multiple Myeloma Patients After Stem Cell Transplantation
ItalyStudy on Ravulizumab for Adults with Immunoglobulin A Nephropathy (IgAN) to Preserve Kidney Function
ItalyStudy of venetoclax and azacitidine treatment in adults with NPM1-mutated acute myeloid leukemia who experience molecular relapse or disease progression
ItalyStudy on the Long-term Safety and Effectiveness of Danicopan with Ravulizumab or Eculizumab for Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH)
ItalyStudy on the Safety and Effectiveness of Polatuzumab Vedotin with Rituximab, Gemcitabine, and Oxaliplatin for Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma
ItalyThe busiest research cities in the country
What the registry says about research in the country
Innovative trials exploring treatments for Acute Myeloid Leukemia and Lymphomas, including studies on targeted therapies combined with standard chemotherapy. Research focuses on improving treatment outcomes for various blood cancers.
Advanced therapeutic approaches aim to enhance minimal residual disease control and patient outcomes.
Comprehensive research into ovarian cancer treatments, including studies of maintenance therapies and novel drug combinations. Investigations focus on both recurrent and newly diagnosed cases.
Studies emphasize personalized treatment approaches based on specific genetic markers and disease characteristics.
Groundbreaking research in lung cancer and severe respiratory conditions, including targeted therapies for specific genetic mutations and innovative treatment combinations.
Focus on developing personalized treatment strategies for various lung cancer subtypes and respiratory conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
